Determinants of Multidrug-Resistant Mycobacterium tuberculosis Infection: A Multicenter Study from Southern Ethiopia
2022; Dove Medical Press; Volume: Volume 15; Linguagem: Inglês
10.2147/idr.s363628
ISSN1178-6973
AutoresAbdulkerim Badgeba, Mulugeta Shegaze Shimbre, Mathewos Alemu Gebremichael, Biruk Bogale, Menur Berhanu, Hanan Abdulkadir,
Tópico(s)Infectious Diseases and Tuberculosis
ResumoMultidrug-resistant tuberculosis (MDR-TB) continues to be a public health problem. Globally in 2019, a total of 465,000 people developed rifampicin-resistant TB (RR-TB), of which 78% had MDR-TB. There is a paucity of evidence on the determinants of MDR-TB in southern Ethiopia. Hence, this study aimed to assess the determinants of MDR-TB in southern Ethiopia.
Referência(s)